Cas:210972-11-5 7-benzyl-3,4-dihydro-2H-naphthalen-1-one manufacturer & supplier

Chemical Name:7-benzyl-3,4-dihydro-2H-naphthalen-1-one

CAS.NO:210972-11-5

Synonyms:3,4-dihydro-7-(phenylmethyl)-1(2H)-Naphthalenone;7-Benzyl-3,4-dihydronaphthalen-1(2H)-one

Molecular Formula:C₁₇H₁₆O

Molecular Weight:236.30800

HS Code:2914399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:17.07000

Exact Mass:236.12000

LogP:3.79640

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3,4-dihydro-7-(phenylmethyl)-1(2H)-Naphthalenone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-Benzyl-3,4-dihydronaphthalen-1(2H)-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,4-dihydro-7-(phenylmethyl)-1(2H)-Naphthalenone Use and application,3,4-dihydro-7-(phenylmethyl)-1(2H)-Naphthalenone technical grade,usp/ep/jp grade.

Related News: You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs. 7-benzyl-3,4-dihydro-2H-naphthalen-1-one manufacturer Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 7-benzyl-3,4-dihydro-2H-naphthalen-1-one supplier As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. 7-benzyl-3,4-dihydro-2H-naphthalen-1-one vendor If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such. 7-benzyl-3,4-dihydro-2H-naphthalen-1-one factory As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.